From Traditional Trial To DCT: Four Keys For Small To Mid-Sized Companies

Over the past decade, many new technologies have helped automate the management of clinical trials and their related data. Other advances have enabled patients to monitor their health by reading their glucose and oxygen levels, heart rate, blood pressure—even balance. These developments have combined with a growing awareness of the inequities in access to traditional trials, and together are fueling interest in and demand for decentralized clinical trials (DCTs). As DCTs gain ground, small to midsized sponsors face new challenges—many of which can be solved by technology.